Denali Therapeutics Inc. (DNLI) › Total AssetsDenali Therapeutics Inc. (DNLI) — Total AssetsAnnual figures by period end, from SEC filings.2017-12-31: $486.72M2018-12-31: $661.98M2019-12-31: $553.23M2020-12-31: $1.60B2021-12-31: $1.40B2022-12-31: $1.46B2023-12-31: $1.15B2024-12-31: $1.37B2025-12-31: $1.14B$1.14B2017-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$1.14B-16.7%2026-02-26Balance as of period end2024-12-31$1.37B+19.1%2026-02-26Balance as of period end2023-12-31$1.15B-21.0%2025-02-27Balance as of period end2022-12-31$1.46B+4.0%2024-02-28Balance as of period end2021-12-31$1.40B-12.5%2023-02-27Balance as of period end2020-12-31$1.60B+190.0%2022-02-28Balance as of period end2019-12-31$553.23M-16.4%2021-02-26Balance as of period end2018-12-31$661.98M+36.0%2020-02-27Balance as of period end2017-12-31$486.72M—2019-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)